Claire underwent surgery to remove the melanoma and was told she was cancer-free but two years later she felt a lump in her stomach ...

Licensing agreement deal value for innovative T-cell receptor (TCR) immunotherapy drugs surged in 2024, with European ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...

A newly approved immunotherapy can help adults with a difficult-to-treat form of leukemia, clinical trial results show ...

Thanks to the revolutionary advancements in CRISPR technology, medical specialists are on the verge of transforming how we ...

Innovent Biologics (HK:1801) has released an update. Innovent Biologics has announced that its TYVYT® (sintilimab injection) ...

The Data Safety Monitoring Board (DSMB) stated no safety concerns, and recommended continuation of BriaCell’s pivotal Phase 3 study of Bria-IMT™ ...

BriaCell Therapeutics (BCT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Emily ...

New insights into the impact of checkpoint inhibitors on the immune system may enhance cancer treatment strategies. A ...

Study uses spatial transcriptomics to map intratumoral heterogeneity and microenvironmental dynamics in triple-negative ...

Now approved in over 20 cancer types and used in earlier lines of therapy, immune checkpoint inhibitors (ICIs) have ...

Neighbours icon Ian Smith has exited the soap, after announcing that he has been diagnosed with terminal cancer. The star, ...